Med. praxi. 2021;18(2):113-116 [Neurol. praxi. 2020;21(3):226-229]

Current position of nimesulide in a variety of non-opioid analgesics

MUDr. Jiří Slíva, Ph.D.
Ústav farmakologie, 3. LF UK, Praha

Non-steroidal anti-inflammatory drugs (NSAIDs) are the cornerstone of the treatment of a wide range of painful conditions. Their efficiency and safety are well known. For more than three decades, nimesulide has been a successful representative of a subgroup of preferentially-acting NSAIDs. This text summarizes its basic characteristics, in the context of its obvious benefits and potential risks that define its position among other NSAIDs.

Keywords: NSAIDs, non-steroidal anti-inflammatory drugs, pain, analgesics, nimesulide, cyclooxygenase, safety, hepatotoxicity.

Published: April 30, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Slíva J. Current position of nimesulide in a variety of non-opioid analgesics. Med. praxi. 2021;18(2):113-116.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Prochazkova M, Dolezal T, Sliva J, Krsiak M. Different patterns of spinal cyclooxygenase-1 and cyclooxygenase-2 mRNA expression in inflammatory and postoperative pain. Basic Clin Pharmacol Toxicol. 2006; 99: 173-177. Go to original source... Go to PubMed...
    2. Singla AK, Chawla M, Singh A. Nimesulide: some pharmaceutical and pharmacological aspects - an update. J Pharm Pharmacol 2000; 52: 467-486. Go to original source... Go to PubMed...
    3. Suleyman H, Cadirci E, Albayrak A, Halici Z. Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug. Curr. Med Chem 2008; 15: 278-283. Go to original source... Go to PubMed...
    4. Auteri A, Bruni F, Blardi P, Di Renzo M, Pasqui AL, Saletti M, Verzuri MS, Scaricabarozi I, Vargiu G, Di Perri T. Clinical study on pharmacological interaction between nimesulide and warfarin. Int J Clin Pharmacol Res 1991; 11: 267-270.
    5. Milsom I, Andersch B. Effect of ibuprofen, naproxen sodium and paracetamol on intrauterine pressure and menstrual pain in dysmenorrhoea. Br. J Obstet. Gynaecol. 1984; 91: 1129-1135. Go to original source... Go to PubMed...
    6. Lopez RC, Cisneros Lugo JH, Romo Enciso LJ, Garcia Sandoval MG. Nimesulide in the treatment of primary dysmenorrhea. Comparative clinical evaluation with mefenamic acid and fentiazac. Ginecol. Obstet. Mex. 1989; 57: 196-201. Go to PubMed...
    7. Ward A, Brogden RN. Nimesulide. A preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain states. Drugs 1988; 36: 732-753. Go to original source... Go to PubMed...
    8. Melis GB, Paoletti AM, Mais V, Ajossa S, Guerriero S. Controlled clinical study of the efficacy and tolerability of methoxybutropate compared to nimesulide in gynecology. Minerva Ginecol. 1997; 49: 409-415. Go to PubMed...
    9. Montoneri C, Garofalo A, Iurato S, Scaricabarozzi I, Trezzani R. Clinical study of the efficacy and tolerability of nimesulide in suppositories compared to flurbiprofen in gynecology. Minerva Ginecol. 1990; 42: 413-419. Go to PubMed...
    10. Pulkkinen M. Nimesulide in dysmenorrhoea. Drugs 1993; 46(Suppl 1): 129-133. Go to original source... Go to PubMed...
    11. Facchinetti F, Piccinini F, Sgarbi L, Renzetti D. Nimesulide in the treatment of primary dysmenorrhea: a double-blind study versus diclofenac. Drugs of Today 2001; 37: 39-45. Go to original source...
    12. Lethaby A, Augood C, Duckitt K. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane.Database. Syst. Rev 2002; CD000400.
    13. Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane. Database. Syst. Rev 2015; CD001751. Go to original source...
    14. Bessone F. Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage? World J. Gastroenterol. 2010; 16: 5651-5661. Go to original source... Go to PubMed...
    15. Traversa G, Bianchi C, Da CR, Abraha I, Menniti-Ippolito F, Venegoni M. Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs. BMJ 2003; 327: 18-22. Go to original source... Go to PubMed...
    16. Donati M, Conforti A, Lenti MC, Capuano A, Bortolami O, Motola D, Moretti U, Vannacci A, Rufaniello C, Vaccheri A, Arzenton E, Bonaiuti R, Sportiello L, Leone R, DILI-IT Group. Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case-control study in Italy. Br. J Clin Pharmacol 2016; 82: 238-248. Go to original source... Go to PubMed...
    17. Walker SL, Kennedy F, Niamh N, McCormick PA. Nimesulide associated fulminant hepatic failure. Pharmacoepidemiol. Drug Saf 2008; 17: 1108-1112. Go to original source... Go to PubMed...
    18. Kwon J, Kim S, Yoo H, Lee E. Nimesulide-induced hepatotoxicity: a systematic review and meta-analysis. PLoS. One. 2019; 14: e0209264. Go to original source... Go to PubMed...
    19. Monteiro JP, Martins AF, Lucio M, Reis S, Pinheiro TJT, Geraldes CFGC, Oliveira PJ, Jurado AS. Nimesulide interaction with membrane model systems: are membrane physical effects involved in nimesulide mitochondrial toxicity? Toxicol. In Vitro 2011; 25: 1215-1223. Go to original source... Go to PubMed...
    20. Borges RS, Oliveira JP, Matos RF, Chaves Neto AM, Carneiro AS, Monteiro MC. Involvement of electron and hydrogen transfers through redox metabolism on activity and toxicity of the nimesulide. J Mol Model. 2015; 21: 166. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.